Status:
RECRUITING
A Multicenter Prospective Observational Cohort Based on a Breast Cancer Medical Record Database in China
Lead Sponsor:
Fudan University
Conditions:
Breast Neoplasms
Eligibility:
All Genders
Brief Summary
1. To construct a prospective, multi-center breast cancer treatment cohort in China, and analyze the factors affecting breast cancer diagnosis and treatment. 2. To evaluate the diagnosis and treatment...
Detailed Description
This research aims to: A. Understand and analyze the current status of breast cancer diagnosis and treatment; B. Publish an annual report on diagnosis and treatment; C. Data sharing, dynamic evaluati...
Eligibility Criteria
Inclusion
- Patients with malignant breast tumors must be diagnosed by cytology or histology, and their pathological types include but are not limited to breast carcinoma in situ, invasive carcinoma, and breast sarcoma.
Exclusion
- None
Key Trial Info
Start Date :
July 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
20000 Patients enrolled
Trial Details
Trial ID
NCT06591039
Start Date
July 1 2022
End Date
December 31 2025
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Hospital/ Institute, Fudan University
Shanghai, Shanghai Municipality, China, 200032